The Treatment of Primary and Metastatic Hepatic Neoplasms Using Percutaneous Cryotherapy

 

 Buy Article Permissions and Reprints

ABSTRACT

Cryotherapy has been used clinically in the treatment of metastatic liver malignancies since the 1980s. Rapid freezing to sub-zero temperatures promotes ice formation in the extracellular space and the exit of intracellular water. Cellular death is the result of dehydration, protein denaturation, and microcirculatory failure. Cryotherapy probes use nitrogen or argon gas as a coolant and the development of the ice ball can be monitored using ultrasound, computed tomography, or magnetic resonance imaging. Traditionally, cryotherapy has been performed during laparoscopy or laparotomy, using intraoperative ultrasound for image guidance. A decrease in cryoprobe size (from ~24 Fr to ~15 gauge) in conjunction with experience gained in open cryosurgical treatment has allowed the development of minimally invasive percutaneous approaches. In this review, we describe the use of cryotherapy for treatment of primary or secondary liver neoplasms using a percutaneous approach.

REFERENCES

• 1 Staley C A. Surgical therapy of hepatic tumors. In: Zakim D, Boyer TD Hepatology: A Textbook of Liver Disease. Philadelphia; Saunders 2003: 1371-1381
  Google Scholar
• 2 Scheele J. Hepatectomy for liver metastases.  Br J Surg. 1993;  80 274-276
  CrossrefPubMedGoogle Scholar
• 3 Gilbert H A, Kagan A R. Metastases: incidence, detection and evaluation without histologic confirmation. In: Weiss L Fundamental Aspects of Metastases. Amsterdam; North Holland Publishing 1976: 385-405
  Google Scholar
• 4 Geoghegan J G, Scheele J. Treatment of colorectal liver metastasis.  Br J Surg. 1999;  86 158-169
  CrossrefPubMedGoogle Scholar
• 5 Allen-Mersh T G, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.  Lancet. 1994;  344 1255-1260
  CrossrefPubMedGoogle Scholar
• 6 Goldberg S N, Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma.  J Clin Gastroenterol. 2002;  35 S115-S129
  CrossrefPubMedGoogle Scholar
• 7 Ravikumar T S, Steele Jr G D. Hepatic cryosurgery.  Surg Clin North Am. 1989;  69 433-440
  PubMedGoogle Scholar
• 8 McCarthy T, Kuhn J A. Cryotherapy for liver tumors.  Oncology. 1998;  12 979-993
  PubMedGoogle Scholar
• 9 Cuschieri A, Crosthwaite G, Shimi S et al.. Hepatic cryotherapy for liver tumors: development and clinical evaluation of a high-efficiency insulated multineedle probe system for open and laparoscopic use.  Surg Endosc. 1995;  9 483-489
  PubMedGoogle Scholar
• 10 Adam R, Majno P, Castaing D et al.. Treatment of irresectable liver tumors by percutaneous cryosurgery.  Br J Surg. 1998;  85 1493-1494
  CrossrefPubMedGoogle Scholar
• 11 Frezza E E. Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses.  Dig Dis Sci. 2004;  49 866-871
  CrossrefPubMedGoogle Scholar
• 12 Farmer D G, Rosove M H, Shaked A et al.. Current treatment modalities for HCC.  Ann Surg. 1994;  219 236-247
  PubMedGoogle Scholar
• 13 Zibari G B, Riche A, Zizzi H C et al.. Surgical and non-surgical management of primary and metastatic liver tumors.  Am Surg. 1998;  64 211-220
  PubMedGoogle Scholar
• 14 Nagasue N, Yukay H, Ogawa Y et al.. Clinical experience with 118 hepatic resections for HCC.  Surgery. 1986;  99 694-701
  PubMedGoogle Scholar
• 15 Wu M, Chen H, Yao X. Surgical treatment of primary liver cancer.  Zhonghua Wai Ke Za Zhi. 1996;  34 707-710
  PubMedGoogle Scholar
• 16 Moreno Gonzalez E, Gomez R, Garcia I et al.. Liver transplantation in malignant hepatic neoplasms.  Am J Surg. 1992;  163 395-400
  CrossrefPubMedGoogle Scholar
• 17 Mazzaferro V, Regalia E, Doci R et al.. Liver transplantation for the treatment of small HCC in patients with cirrhosis.  N Engl J Med. 1996;  334 693-699
  CrossrefPubMedGoogle Scholar
• 18 Pichlmayr R, Weimann A, Oldhafer K J et al.. Role of liver transplantation in the treatment of unresectable liver cancer.  World J Surg. 1995;  19 807-813
  CrossrefPubMedGoogle Scholar
• 19 Selby R, Kadry Z, Carr B et al.. Liver transplantation for HCC.  World J Surg. 1995;  19 53-58
  CrossrefPubMedGoogle Scholar
• 20 Gugenheim J, Baldini E, Casaccia M et al.. Hepatic resection and transplantation for HCC in patients with cirrhosis.  Gastroenterol Clin Biol. 1997;  21 590-595
  PubMedGoogle Scholar
• 21 Geoghegan J G, Scheele J. Treatment of colorectal liver metastases.  Br J Surg. 1999;  86 158-169
  CrossrefPubMedGoogle Scholar
• 22 Holbrook R F, Koo K, Ryan J A. Resection of malignant primary liver tumors.  Am J Surg. 1996;  171 453-455
  CrossrefPubMedGoogle Scholar
• 23 Huscher C GS, Lirici M M, Crafa F, Corradi A, Recher A. The technique of laparoscopic liver resection. 7th World Congress of Endoscopic Surgery. Singapore; 2000: 497-506
  Google Scholar
• 24 Nerenstone S R, Ihde D C, Friedman M A. Clinical trials in primary hepatocellular carcinoma: current status and future directions.  Cancer Treat Rev. 1988;  15 1-31
  PubMedGoogle Scholar
• 25 Colleoni M, Gaion F, Liessi G et al.. Medical treatment of hepatocellular carcinoma: any progress?.  Tumori. 1994;  80 315-326
  PubMedGoogle Scholar
• 26 Falkson G, Moertel C, Lavin P et al.. Chemotherapy studies in primary liver cancer: a prospective randomised clinical trial.  Cancer. 1978;  42 2149-2156
  PubMedGoogle Scholar
• 27 Brennan M, Taley R, San Diego E et al.. Critical analysis of 594 cancer patients treated with 5-FU. In: Platner A Proceedings of the International Symposium on Chemotherapy of Cancer. New York; Elsevier 1964: 118-119
  Google Scholar
• 28 Chlebowski R, Brzechwa-Adjukiewicz A, Cowden A et al.. Doxorubicin for HCC: clinical and pharmacokinetic results.  Cancer Treat Rep. 1984;  68 487-491
  PubMedGoogle Scholar
• 29 Lai C L, Wu P C, Chan G CB et al.. Doxorubicin versus no anti-tumor therapy in inoperable HCC: a prospective randomised trial.  Cancer. 1988;  62 479-483
  CrossrefPubMedGoogle Scholar
• 30 Broder L E, Carter S K. Pancreatic islet cell carcinoma: results of therapy with streptozotocin in 52 patients.  Ann Intern Med. 1973;  79 108-118
  PubMedGoogle Scholar
• 31 Kessinger A, Foley J F, Lemon H M. Therapy of malignant APUD cell tumors: effectiveness of DTIC.  Cancer. 1983;  51 790-794
  PubMedGoogle Scholar
• 32 Moertel C G, Johnson C M, McKusick M A et al.. The management of patients with advanced carcinoid tumors and islet cell carcinomas.  Ann Intern Med. 1994;  120 302-309
  CrossrefPubMedGoogle Scholar
• 33 Folprecht G, Grothey A, Alberts S, Raab H R, Kohne C H. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.  Ann Oncol. 2005;  16 1311-1319
  CrossrefPubMedGoogle Scholar
• 34 Cunningham D, Humblet Y, Siena S et al.. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.  N Engl J Med. 2004;  351 337-345
  CrossrefPubMedGoogle Scholar
• 35 Hurwitz H, Fehrenbacher L, Novotny W et al.. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.  N Engl J Med. 2004;  350 2335-2342
  CrossrefPubMedGoogle Scholar
• 36 McGahan J P, Browning P D, Brock J M, Teslik H. Hepatic ablation using radiofrequency electrocautery.  Invest Radiol. 1990;  25 267-270
  CrossrefPubMedGoogle Scholar
• 37 Rossi P. Radiofrequency ablation of the liver tumours. Paper presented at International Symposium on Endovascular Therapy. Miami Beach, FL; January 23-27, 1999
  Google Scholar
• 38 Curley S A, Davidson B S, Fleming R Y et al.. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver.  Surg Endosc. 1997;  11 729-733
  CrossrefPubMedGoogle Scholar
• 39 Solbiati L, Ierace T, Goldberg S N et al.. Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.  Radiology. 1997;  202 195-203
  CrossrefPubMedGoogle Scholar
• 40 Livraghi T, Goldberg S N, Monti F et al.. Saline enhanced radiofrequency tissue ablation in the treatment of liver metastases.  Radiology. 1997;  202 205-210
  PubMedGoogle Scholar
• 41 Curley S A, Izzo F, Delrio P et al.. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.  Ann Surg. 1999;  230 1-8
  CrossrefPubMedGoogle Scholar
• 42 Jiao L R, Hansen P D, Havlik R, Mitry R R, Pignatelli M, Habib N. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.  Am J Surg. 1999;  177 303-306
  CrossrefPubMedGoogle Scholar
• 43 Lencioni R, Goletti O, Armillotta N et al.. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial.  Eur Radiol. 1998;  8 1205-1211
  CrossrefPubMedGoogle Scholar
• 44 Marone G, Francica G, D'Angelo V et al.. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle].  Radiol Med (Torino). 1998;  95 624-629
  PubMedGoogle Scholar
• 45 Francica G, Marone G. Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a cooled tip needle: a preliminary clinical experience.  Eur J Ultrasound. 1999;  9 145-153
  CrossrefPubMedGoogle Scholar
• 46 Kainuma O, Asano T, Aoyama H et al.. Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer.  Hepatogastroenterology. 1999;  46 1071-1077
  PubMedGoogle Scholar
• 47 Buscarini L, Buscarini E, Di Stasi M, Quaretti P, Zangrandi A. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma.  Ultraschall Med. 1999;  20 47-53
  Article in Thieme ConnectPubMedGoogle Scholar
• 48 Holtkamp W, Muller W. [Ultrasonically controlled percutaneous high frequency thermotherapy of liver tumours with perfused needle electrodes].  Z Gastroenterol. 2000;  38 221-227
  PubMedGoogle Scholar
• 49 Livraghi T, Goldberg S N, Lazzaroni S et al.. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions.  Radiology. 2000;  214 761-768
  CrossrefPubMedGoogle Scholar
• 50 Tranberg K G. Percutaneous ablation of liver tumours.  Best Pract Res Clin Gastroenterol. 2004;  18 125-145
  CrossrefPubMedGoogle Scholar
• 51 Mulier S, Mulier P, Ni Y et al.. Complications of radiofrequency coagulation of liver tumours.  Br J Surg. 2002;  89 1206-1222
  CrossrefPubMedGoogle Scholar
• 52 Adam A. Interventional radiology in the treatment of hepatic metastases.  Cancer Treat Rev. 2002;  28 93-99
  CrossrefPubMedGoogle Scholar
• 53 Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.  Clin Liver Dis. 2005;  9 301-314
  CrossrefPubMedGoogle Scholar
• 54 Livraghi T, Goldberg S N, Lazzaroni S et al.. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection.  Radiology. 1999;  210 655-661
  CrossrefPubMedGoogle Scholar
• 55 Xu K C, Niu L Z, He W B, Guo Z Q, Hu Y Z, Zuo J S. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma.  World J Gastroenterol. 2003;  9 2686-2689
  PubMedGoogle Scholar
• 56 Koda M, Murawaki Y, Mitsuda A et al.. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.  Cancer. 2001;  92 1516-1524
  CrossrefPubMedGoogle Scholar
• 57 Copper I S. Cryogenic surgery: a new method of destruction of extirpation of benign or malignant tissues.  N Engl J Med. 1963;  268 743-749
  PubMedGoogle Scholar
• 58 Ravikumar T S, Steele Jr G D. Hepatic cryosurgery.  Surg Clin North Am. 1989;  69 433-440
  PubMedGoogle Scholar
• 59 Seifert J K, Morris D L. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer.  Br J Surg. 1999;  86 234-240
  CrossrefPubMedGoogle Scholar
• 60 Ross W B, Horton M, Bertolino P, Morris D L. Cryotherapy of liver tumours: a practical guide.  HPB Surg. 1995;  8 167-173
  PubMedGoogle Scholar
• 61 Silverman S G, Sun M RM, Tuncali K et al.. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases.  AJR Am J Roentgenol. 2004;  183 707-712
  CrossrefPubMedGoogle Scholar
• 62 Kuszyk B S, Choti M A, Urban B A et al.. Hepatic tumors treated by cryosurgery: normal CT appearance.  AJR Am J Roentgenol. 1996;  166 363-368
  PubMedGoogle Scholar
• 63 Silverman S G, Collick B D, Figueira M R et al.. Interactive MR-guided biopsy in an open-configuration MR imaging system.  Radiology. 1995;  197 175-181
  PubMedGoogle Scholar
• 64 Zhou X D, Tang Z Y, Yu Y Q et al.. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases.  J Cancer Res Clin Oncol. 1993;  120 100-102
  CrossrefPubMedGoogle Scholar
• 65 Huang A, McCall J M, Weston M D et al.. Phase I study of percutaneous cryotherapy for colorectal liver metastasis.  Br J Surg. 2002;  89 303-310
  CrossrefPubMedGoogle Scholar
• 66 Seifert J K, Junginger T h. Prognostic factors for cryotherapy of colorectal liver metastases.  Eur J Surg Oncol. 2004;  30 34-40
  CrossrefPubMedGoogle Scholar
• 67 Rosen C B, Nagorney D M, Taswell H F et al.. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma.  Ann Surg. 1992;  216 493-505
  CrossrefPubMedGoogle Scholar
• 68 Seifert J K, Morris D L. World survey on the complications of hepatic and prostate cryotherapy.  World J Surg. 1999;  23 109-114
  CrossrefPubMedGoogle Scholar
• 69 Ng K K, Lam C M, Poon R T et al.. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model.  Ann Surg Oncol. 2004;  11 650-657
  CrossrefPubMedGoogle Scholar
• 70 Crews K A, Kuhn J A, McCarty T M et al.. Cryosurgical ablation of hepatic tumors.  Am J Surg. 1997;  174 614-617
  CrossrefPubMedGoogle Scholar
• 71 Adam R, Akpinar E, Johann M et al.. Place of cryosurgery in the treatment of malignant liver tumors.  Ann Surg. 1997;  225 39-48
  CrossrefPubMedGoogle Scholar
• 72 Zhou X D, Tang Z Y. Management of hepatocellular carcinoma: longterm outcome in 2639 cases.  Gan To Kagaku Ryoho. 1997;  24 9-16
  PubMedGoogle Scholar
• 73 Zhou X D, Tang Z Y, Yu Y Q et al.. Clinical evaluation of cryosurgery in the treatment of primary liver cancer: report of 60 cases.  Cancer. 1988;  61 1889-1892
  PubMedGoogle Scholar
• 74 Wong W S, Patel S C, Cruz F S et al.. Cryosurgery as a treatment for advanced-stage hepatocellular carcinoma: results, complications, and alcohol ablation.  Cancer. 1998;  82 1268-1278
  CrossrefPubMedGoogle Scholar
• 75 Cha C, Lee F T, Rikkers L F et al.. Rationale for the combination of cryoablation with surgical resection of hepatic tumors.  J Gastrointest Surg. 2001;  5 206-213
  CrossrefPubMedGoogle Scholar
• 76 Bilchik A J, Wood T F, Allefra D P et al.. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms.  Arch Surg. 2000;  135 657-664
  PubMedGoogle Scholar
• 77 Seifert J K, Morris D L. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer.  Ann Surg. 1998;  228 201-208
  CrossrefPubMedGoogle Scholar
• 78 Mala T, Edwin B, Mathisen O et al.. Cryoablation of colorectal liver metastases: minimally invasive tumour control.  Scand J Gastroenterol. 2004;  39 571-578
  CrossrefPubMedGoogle Scholar
• 79 Cozzi P J, Englund R, Morris D L. Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors.  Cancer. 1995;  76 501-509
  PubMedGoogle Scholar
• 80 Seifert J K, Cozzi P J, Morris D L. Cryotherapy for neuroendocrine liver metastases.  Semin Surg Oncol. 1998;  14 175-183
  CrossrefPubMedGoogle Scholar
• 81 Shapiro R S, Shafir M, Sung M, Warner R, Glajchen N. Cryotherapy of metastatic carcinoid tumors.  Abdom Imaging. 1998;  23 314-317
  CrossrefPubMedGoogle Scholar

Charles E RayJr. 

M.D., Department of Radiology

Denver Health, 777 Bannock Street, MC 0024, Denver, CO 80204